Trial intelligence / Profile preview

Acute Effects of Sildenafil on Endothelial Function in Type 2 Diabetes

NCT00527995Phase 3Completed

Sponsor
Ruhr University Bochum
Start
Aug 2001
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of ASP-001 in endothelial dysfunction (2 arms), sponsored by Ruhr University Bochum. Primary endpoint: Flow Mediated Dilatation at 60 minutes. Started Aug 2001; status: completed.

02

Drugs

ASP-001
03

Conditions

endothelial dysfunction

Beyond the preview

Go deeper on NCT00527995.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00527995.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call